CYP1A1 and breast carcinoma: Our results confirm the hypothesis that CYP1A1Ile462Val, in association with a long period of active smoking, could be a possible breast cancer risk factor and also support the main effect of CYP1A1 in estrogenic metabolism rather than in tobacco carcinogen activation in breast cancer patients.